Back to blog
Done Deals
Sekkei Bio secures Series A co-led by Tenshi Pharmaceuticals & Ashish Kacholia
Done Deals
A landmark deep-tech raise — matched and momentum-built through the platform.
Deep-tech and life-sciences companies are among the hardest to match with the right capital. This raise shows what's possible when conviction on both sides aligns.
The raise
Sekkei Bio secured Series A funding co-led by Tenshi Pharmaceuticals and marquee investor Ashish Kacholia — a strong signal of confidence in the company's science and trajectory.
Why it matters
Strategic and growth capital for frontier science is active. For founders building in deep tech, the right introductions can shorten a years-long fundraising journey to weeks.